Cargando…
Safety Concerns of Nasal Corticosteroids Usage in Patients With Allergic Rhinitis
Background Intranasal corticosteroids (INCSs) are the first-line treatment for patients with moderate to severe conditions of allergic rhinitis (AR) as per current guidelines. However, patients' knowledge and practice towards the safety of such medications remains ambiguous. Therefore, this stu...
Autores principales: | Almutairi, Talal A, Aldayel, Abdulaziz A, Aldayel, Abdulrahman S, Alotaibi, Fahad, Alhussain, Hamad A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686935/ https://www.ncbi.nlm.nih.gov/pubmed/33251078 http://dx.doi.org/10.7759/cureus.11651 |
Ejemplares similares
-
Parental Knowledge of Children's Developmental Milestones in Riyadh, Saudi Arabia
por: Aldayel, Abdulrahman S., et al.
Publicado: (2020) -
Maternal awareness to the timing of allergenic food introduction in Saudi infants: A cross-sectional study
por: Almutairi, Ahmed M., et al.
Publicado: (2021) -
Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis
por: Rajput, Muhammad Shaheryar Ahmed, et al.
Publicado: (2020) -
The Relationship between Chemokine Ligand 3 and Allergic Rhinitis
por: Berghi, Ovidiu, et al.
Publicado: (2020) -
Problem-based learning: medical students’ perception toward their educational environment at Al-Imam Mohammad Ibn Saud Islamic University
por: Aldayel, Abdulaziz Abdulrahman, et al.
Publicado: (2019)